These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1375676

  • 1. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J, Akima M, Nabata H, Taira N.
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [Abstract] [Full Text] [Related]

  • 2. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T, Iwai T, Haruta K, Takeda K.
    Arch Int Pharmacodyn Ther; 1996 Jan; 331(3):273-84. PubMed ID: 9124999
    [Abstract] [Full Text] [Related]

  • 3. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K, Yamada H, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [Abstract] [Full Text] [Related]

  • 4. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F, Satoh K, Taira N.
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
    Nakae I, Quan L, Hashimoto K, Sugimoto Y, Tsutamoto T, Kinoshita M.
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
    [Abstract] [Full Text] [Related]

  • 6. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T, Angus JA.
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [Abstract] [Full Text] [Related]

  • 7. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A, Kaneta S, Motoki K, Jinno Y, Kasai H, Okada Y, Fukushima H, Ogawa N.
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y, Kaneta S, Okada Y, Yokoyama T, Jinno Y, Fukushima H, Ogawa N.
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [Abstract] [Full Text] [Related]

  • 9. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
    Satoh K, Mori T, Yamada H, Taira N.
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
    [Abstract] [Full Text] [Related]

  • 10. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H, Yoneyama F, Satoh K, Taira N.
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs.
    Berdeaux A, Drieu la Rochelle C, Richard V, Giudicelli JF.
    J Cardiovasc Pharmacol; 1992 Jul; 20 Suppl 3():S17-21. PubMed ID: 1282171
    [Abstract] [Full Text] [Related]

  • 12. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T, Tomaru T, Miwa A, Nakamura F, Kido H, Sugimoto T, Uchida Y.
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
    [Abstract] [Full Text] [Related]

  • 13. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
    Nakae I, Quan L, Sugimoto Y, Tsutamoto T, Kinoshita M.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments.
    Ishiyama T, Dohi S, Iida H, Akamatsu S, Ohta S, Shimonaka H.
    Stroke; 1994 Aug; 25(8):1644-50. PubMed ID: 8042218
    [Abstract] [Full Text] [Related]

  • 15. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T, Teshigawara T, Taira N.
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [Abstract] [Full Text] [Related]

  • 16. Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.
    Yanagisawa T, Yamagishi T, Okada Y.
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():565-74. PubMed ID: 8251426
    [Abstract] [Full Text] [Related]

  • 17. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
    Satoh E, Yanagisawa T, Taira N.
    Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
    [Abstract] [Full Text] [Related]

  • 18. Effect of KRN2391 on venous return: comparison with other vasodilators.
    Kaneta S, Jinno Y, Miwa A, Fukushima H, Ogawa N.
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101
    [Abstract] [Full Text] [Related]

  • 19. Spasmolytic effect of cromakalim in dog coronary artery in vitro.
    McPherson GA, Keily SG, Angus JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):519-24. PubMed ID: 1908952
    [Abstract] [Full Text] [Related]

  • 20. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
    Kreye VA, Lenz T, Theiss U.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.